(Q42970937)

12 November 2017

title

Lowered cardiac sympathetic nerve performance in response to exercise in Parkinson's disease (English)

1 reference

12 November 2017

1 reference

7

Gen Sobue

1 reference

12 November 2017

Tomohiko Nakamura

1

1 reference

12 November 2017

Masaaki Hirayama

2

1 reference

12 November 2017

Fumitada Yamashita

3

1 reference

12 November 2017

Kei Uchida

4

1 reference

12 November 2017

Tetsuo Hama

5

1 reference

12 November 2017

Hirohisa Watanabe

6

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

12 November 2017

1 reference

12 November 2017

volume

25

1 reference

12 November 2017

issue

9

1 reference

12 November 2017

page(s)

1183-1189

1 reference

Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson's disease

12 November 2017

cites work

1 reference

Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA.

21 January 2018

1 reference

(123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease

21 January 2018

1 reference

Attenuated pre-ejection period response to tyramine in patients with cardiac sympathetic denervation

21 January 2018

1 reference

Functional effects of cardiac sympathetic denervation in neurogenic orthostatic hypotension

21 January 2018

1 reference

Electrophysiologic principles and theory of stroke volume determination by thoracic electrical bioimpedance

21 January 2018

1 reference

Utility of impedance cardiography to determine cardiac vs. noncardiac cause of dyspnea in the emergency department

21 January 2018

1 reference

Comparison of changes in ejection fraction to changes in impedance cardiography cardiac index and systolic time ratio

21 January 2018

1 reference

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

21 January 2018

1 reference

Usefulness of rCBF analysis in diagnosing Parkinson's disease: supplemental role with MIBG myocardial scintigraphy

21 January 2018

1 reference

The role of 123I-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic

21 January 2018

1 reference

Cardiac denervation occurs independent of orthostatic hypotension and impaired heart rate variability in Parkinson's disease

21 January 2018

1 reference

Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD.

21 January 2018

1 reference

Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table

21 January 2018

1 reference

Cardiac parasympathetic dysfunction concurrent with cardiac sympathetic denervation in Parkinson's disease.

21 January 2018

1 reference

Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms?

21 January 2018

1 reference

Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease

21 January 2018

1 reference

The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes

21 January 2018

1 reference

Effect of sympathetic reinnervation on cardiac performance after heart transplantation

21 January 2018

1 reference

Norepinephrine and cardiovascular responses to maximal exercise in Parkinson's disease on and off medication.

21 January 2018

1 reference

Cardiovascular dysautonomia in de novo Parkinson's disease

21 January 2018

1 reference

Patient-reported autonomic symptoms in Parkinson disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.23127

1 reference

12 November 2017

1 reference